Showing results (1251-1260 of 1,717) with videos related to

Sort By:
Pageof 172
Cancer Cell|April 26, 2024
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancersSarah T Diepstraten, Yin Yuan, John E La Marca, et al.
Sexually Transmitted Infections|November 24, 2006
Clinic-based evaluation of Clearview Chlamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at high risk in ChinaY-P Yin, R W Peeling, X-S Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Prognostic DNA methylation biomarkers in ovarian cancerSusan H Wei, Curtis Balch, Henry H Paik, et al.
British Journal of Haematology|May 28, 2020
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemiaIng S Tiong, Richard Dillon, Adam Ivey, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia]K Q Liu, Y Wang, Z Zhao, et al.
Genomics|August 15, 1996
A transcription map of the major histocompatibility complex (MHC) class I regionJ R Gruen, S R Nalabolu, T W Chu, et al.
American Journal of Hematology|September 6, 2023
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panelFarhad Ravandi, Jacqueline Cloos, Francesco Buccisano, et al.
JCO Oncology Advances|February 25, 2026
Risk of Residual Cancer following Immediate Surgery or Nonoperative Management after Malignant Colorectal Polypectomy with High-Risk FeaturesThikhamporn Tawantanakorn, A Begum Bektas, Matthew Hill, et al.
The Lancet. Oncology|October 21, 2021
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trialCourtney D DiNardo, Andre C Schuh, Eytan M Stein, et al.
The British Journal of Dermatology|December 6, 2011
Results of carbon ion radiotherapy for skin carcinomas in 45 patientsH Zhang, S Li, X H Wang, et al.
Pageof 172